Your browser doesn't support javascript.
loading
HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models.
Gómez, Valentí; Galazi, Myria; Weitsman, Gregory; Monypenny, James; Al-Salemee, Fahad; Barber, Paul R; Ng, Kenrick; Beatson, Richard; Szokol, Bálint; Orfi, László; Mullen, Greg; Vanhaesebroeck, Bart; Chowdhury, Simon; Leung, Hing Y; Ng, Tony.
Afiliación
  • Gómez V; UCL Cancer Institute, University College London, London, United Kingdom.
  • Galazi M; UCL Cancer Institute, University College London, London, United Kingdom.
  • Weitsman G; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Monypenny J; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Al-Salemee F; School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
  • Barber PR; UCL Cancer Institute, University College London, London, United Kingdom.
  • Ng K; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Beatson R; UCL Cancer Institute, University College London, London, United Kingdom.
  • Szokol B; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Orfi L; Vichem Chemie Ltd., Veszprém, Hungary.
  • Mullen G; Vichem Chemie Ltd., Veszprém, Hungary.
  • Vanhaesebroeck B; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary.
  • Chowdhury S; School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.
  • Leung HY; UCL Cancer Institute, University College London, London, United Kingdom.
  • Ng T; Guy's, King's, and St. Thomas' Hospitals, and Sarah Cannon Research Institute, London, United Kingdom.
Mol Cancer Ther ; 21(4): 667-676, 2022 04 01.
Article en En | MEDLINE | ID: mdl-35086953

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Fosfatidilinositol 3-Quinasas Límite: Humans / Male Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Fosfatidilinositol 3-Quinasas Límite: Humans / Male Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos